News

PAK BioSolutions Raises $12 Million Series A to Expand Continuous Biomanufacturing Product Line

PAK BioSolutions announced that it has raised $12M from Arboretum Ventures, BroadOak Capital Partners, and other investors to expand commercial and product development efforts for its line of automated continuous manufacturing systems for biologics.

The PAK Pilot System is capable of processing 50-500L of cell culture per day, addressing a major segment of the biopharmaceutical production market. With this new financing, PAK will launch its PAK PD benchtop system for lower volume applications, processing 2-10 liters of cellular material per day, and the PAK K-Series system for large-scale commercial manufacturing of 20,000+ liters of material per day. Creation of these systems has required significant R&D resources to address the specific fluid dynamics of each process scale.

“Our expert team of engineers and scientists have worked tirelessly to create new technologies that will enable bioprocess intensification across a breadth of modalities including mAbs, vaccines, recombinant proteins, viral vectors and others. Today is a very exciting day,” said PAK BioSolutions CEO, Joanna Pezzini.

Founded in 2019 by Joanna Pezzini and Kevin Hill-Byrne (CTO), PAK BioSolutions has experienced rapid growth by helping customers achieve a 90% reduction in operator time, 75% reduction in floorplan footprint, and 60% reduction in capital costs compared to traditional biomanufacturing set-ups.

“We have created an out-of-the-box solution, saving biomanufacturing facilities years of development work,” said PAK Co-Founder and CTO, Kevin Hill-Byrne.

“Bringing these new systems to market will revolutionize the field of automated continuous processing for biologics,” said Dan Kidle, who led the investment on behalf of Arboretum and joined PAK’s Board of Directors. “We strive to support technologies that reduce cost and improve quality and have seen an overwhelming response to PAK’s systems.”

The PAK Pilot System won the Interphex Biotech Innovation Award in 2023 and has continually caught the eye of leaders in the industry. End-to-end continuous manufacturing systems for biopharmaceuticals have been gaining interest and entering the GMP manufacturing space. This demand is driven by over 4X productivity improvements, streamlined operations, and a lower risk profile for manufacture and scale-up. To achieve this, all stages of the purification process are operated simultaneously at steady-state.

 

Read more here.

Recent News

02/11/2025

Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment

Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and brain-related health conditions,  announced a strategic partnership with BRAINBox Solutions, a leader in multi-modality diagnostics for traumatic brain injury (TBI). This collaboration seeks to develop the first intranasal therapy for mild traumatic brain injury (mTBI) aka concussion, creating a comprehensive trigger-to-treat

02/10/2025

AIN Ventures and VIPC Invest in Cerbrec to Accelerate AI Innovation

Cerbrec, a leading Virginia-based AI platform provider, announced that AIN Ventures has invested in its seed funding round. This investment will enable Cerbrec to accelerate its mission of equipping biotech and pharmaceutical companies, along with those in other industries, with cutting-edge tools for creating tailored AI solutions. Cerbrec’s flagship product, Graphbook, is an innovative drag-and-drop

02/05/2025

Project Vital bringing millions in funding to Roanoke-Blacksburg’s life sciences

The Roanoke-Blacksburg region is establishing itself as a biomedical research hub and medical device innovation center. About $5 million from the state could help move that work from labs to markets. Those millions will fund Project Vital: Virginia Innovations and Technology Advancements in Life Sciences. It’s a collaboration among the Roanoke-Blacksburg Innovation Alliance (formerly Verge),